Pneumonectomy After High-Dose Radiation and Concurrent Chemotherapy for Nonsmall Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pneumonectomy After High-Dose Radiation and Concurrent Chemotherapy for Nonsmall Cell Lung Cancer

Published:2006-07 Issue:1 Volume:82 Page:227-231
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Daly Benedict D.T.,Fernando Hiran C.,Ketchedjian Ara,DiPetrillo Thomas A.,Kachnic Lisa A.,Morelli Donna M.,Shemin Richard J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference15 articles.

1. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer;Albain;J Clin Oncol,1995

2. Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer;Albain;J Clin Oncol,2002

3. Induction chemoradiation for non-small cell lung carcinomas of the superior sulcus;Rusch;J Thorac Cardiovasc Surg,2001

4. Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer;Stamatis;Eur J Thorac Cardiothorac Surg,2002

5. Postoperative complications after combined neoadjuvant treatment for lung cancer;Fowler;Ann Thorac Surg,1993

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognosis of clinical stage IIIa non‐small cell lung cancer in Taiwan;Cancer Medicine;2023-07-26

2. Mediastinal restaging with transcervical extended mediastinal lymphadenectomy in patients with locally advanced non-small cell lung cancer treated with pneumonectomy;AME Medical Journal;2022-09

3. Comparison of cisplatin-induced nephrotoxicity between single-dose and split-dose administration to rats;Biomedicine & Pharmacotherapy;2022-03

4. Radiation Oncology of Lung Cancer: Why We Fail(ed) in Clinical Research?;Medical Radiology;2021

5. Multimodality Treatment of Stage IIIA/N2 NSCLC: Why Always NO to Surgery?;Medical Radiology;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3